Loading clinical trials...
Loading clinical trials...
Phase 2 Optimization of the Antidepressant Action of Ketamine in Treatment-Resistant Depression and Investigations on Its Mechanism of Action
Conditions
Interventions
Ketamine
Midazolam
Locations
1
Canada
Institute of Mental Health Research, Royal Ottawa Hospital
Ottawa, Ontario, Canada
Start Date
May 1, 2013
Primary Completion Date
December 1, 2017
Completion Date
December 1, 2017
Last Updated
June 26, 2018
NCT05377177
NCT05710237
NCT06784388
NCT05045378
NCT06372834
NCT04670081
Lead Sponsor
University of Ottawa
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions